IRadimed Corporation
IRMD
$85.27
$0.520.61%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 86.28M | 83.81M | 80.51M | 77.64M | 75.15M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 86.28M | 83.81M | 80.51M | 77.64M | 75.15M |
| Cost of Revenue | 19.99M | 19.49M | 18.46M | 17.88M | 17.35M |
| Gross Profit | 66.30M | 64.32M | 62.05M | 59.75M | 57.81M |
| SG&A Expenses | 35.07M | 35.24M | 34.50M | 33.28M | 32.57M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 58.33M | 57.67M | 55.66M | 53.83M | 52.51M |
| Operating Income | 27.95M | 26.15M | 24.85M | 23.81M | 22.65M |
| Income Before Tax | 30.18M | 28.36M | 26.91M | 26.03M | 24.98M |
| Income Tax Expenses | 6.57M | 5.88M | 5.73M | 5.38M | 5.19M |
| Earnings from Continuing Operations | 23.61 | 22.48 | 21.18 | 20.66 | 19.78 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 23.61M | 22.48M | 21.18M | 20.66M | 19.78M |
| EBIT | 27.95M | 26.15M | 24.85M | 23.81M | 22.65M |
| EBITDA | 29.38M | 27.31M | 25.83M | 24.60M | 23.43M |
| EPS Basic | 1.85 | 1.77 | 1.67 | 1.63 | 1.56 |
| Normalized Basic EPS | 1.47 | 1.38 | 1.32 | 1.28 | 1.23 |
| EPS Diluted | 1.83 | 1.75 | 1.65 | 1.62 | 1.55 |
| Normalized Diluted EPS | 1.46 | 1.37 | 1.31 | 1.27 | 1.22 |
| Average Basic Shares Outstanding | 50.96M | 50.89M | 50.83M | 50.78M | 50.73M |
| Average Diluted Shares Outstanding | 51.44M | 51.40M | 51.33M | 51.25M | 51.17M |
| Dividend Per Share | 0.74 | 0.71 | 0.68 | 0.66 | 0.64 |
| Payout Ratio | 65.37% | 66.91% | 39.59% | 39.33% | 39.74% |